Odette Cancer Centre

Toronto, Ontario M4N 3M5

3 studies enrolling now · 12 studies all time

What they study most

Anxiety Disorder, Breast Cancer, Breast Cancer Recurrent, Cognitive/Functional Effects, Colorectal Cancer, Depression, Endometrial Cancer, Excercise, Fatigue, Invasive Breast Cancer, Lymphoma, Melanoma

Studies at this site

• Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer — Recruiting now
• Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) — Recruiting now
• Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER — Recruiting now
• Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer — Completed
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
• Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer — Completed
• Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma — Completed
• Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma — Completed
• Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed